Lupus & antiphospholipid syndrome

Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus

Rheumatology (Oxford)Published Retrospective cohort study

Authors' conclusion

Many patients with active SLE have subclinical depression, and MADRS evaluation of neuropsychiatric symptoms is useful for detecting them. Additionally, the decrease in CSF levels of HVA, SDF-1 α and SCGF-1β reflects the same pathology, and these may serve as surrogate markers.

Study context

Population
SLE patients enrolled 2017–2020 with high disease activity, abnormal CSF, brain MRI or electroencephalography findings, or history of neuropsychiatric illness7 with diffuse neuropsychiatric SLE (NPSLE)
Participants
44 patients
Exposure
MADRS-positive vs MADRS-negative SLE patients
  • MADRS-positiven = 20
  • MADRS-negativen = 24reference
Outcome
PSYRATS positivity rate in SLE patients not diagnosed with diffuse NPSLE

Main finding

As reported in the abstract

PSYRATS positivity in SLE without diffuse NPSLE

Psychiatric symptom rating scales (PSYRATS) positive, 13 of 37 SLE patients without diffuse NPSLE

35.1%

Observational data: associations, not effects.

Further findings

OutcomeP value
CSF HVA, SDF-1α and SCGF-1β concentrationsMADRS-positive vs MADRS-negativeP = 0.0400
CSF HVA, SDF-1α and SCGF-1β concentrationsMADRS-positive vs MADRS-negativeP = 0.0431
CSF HVA, SDF-1α and SCGF-1β concentrationsMADRS-positive vs MADRS-negativeP = 0.0061
CSF homovanillic acid (HVA), SDF-1α and SCGF-1β concentrations — HVA, SDF-1α and SCGF-1β levels correlated with one another
P < 0.05

Original publication

Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus. Rheumatology (Oxford). Published 28 February 2023. doi:10.1093/rheumatology/kead091

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.